GSK: Protocol Summaries: Compounds

Quick Search

By Phase:

By Study Type:

By Population:

By Post Marketing Commitment:

By Status:

By Country:

GSK Study ID	Phase	Title	Status
SAR109935	Phase 1	A Randomized, Double-Blind, Placebo Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK971086 after a Single Dose and 7 Days of Repeat Dosing in Healthy Adult Male Volunteers	Completed